Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Mayes

Showing results (351-360 of 382) with videos related to

Pageof 39
Sort By:
ACR Open Rheumatology|November 26, 2025
Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 TrialDinesh Khanna, Cathie Spino, Donald P Tashkin, et al.
The Journal of Investigative Dermatology|October 18, 2020
Exome-Wide Association Analysis Suggests LRP2BP as a Susceptibility Gene for Endothelial Injury in Systemic Sclerosis in the Han Chinese PopulationWeilin Pu, Wenyu Wu, Qingmei Liu, et al.
Clinical and Experimental Rheumatology|August 29, 2015
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosisEguzkine Ochoa, José-Ezequiel Martin, Shervin Assasi, et al.
Annals of the Rheumatic Diseases|February 28, 2013
New insight on the Xq28 association with systemic sclerosisF David Carmona, M Carmen Cénit, Lina-Marcela Diaz-Gallo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 26, 2019
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialDinesh Khanna, Cathie Spino, Sindhu Johnson, et al.
Arthritis Care & Research|April 20, 2026
Discordance between patient and physician global assessments in early systemic sclerosisEllen Romich, Alexis Ogdie, Alisa Stephens-Shields, et al.
Arthritis Research & Therapy|January 22, 2016
Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patientsMinghua Wu, Shervin Assassi, Gloria A Salazar, et al.
BMJ Open|August 10, 2013
The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease contextLinda Kwakkenbos, Lisa R Jewett, Murray Baron, et al.
Rheumatology (Oxford, England)|June 6, 2018
The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohortsDane H Dougherty, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Clinical and Experimental Rheumatology|January 17, 2012
New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN)Brett D Thombs, Lisa R Jewett, Shervin Assassi, et al.
Pageof 39

Showing results (351-360 of 382) with videos related to

Sort By:
Pageof 39
ACR Open Rheumatology|November 26, 2025
Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 TrialDinesh Khanna, Cathie Spino, Donald P Tashkin, et al.
The Journal of Investigative Dermatology|October 18, 2020
Exome-Wide Association Analysis Suggests LRP2BP as a Susceptibility Gene for Endothelial Injury in Systemic Sclerosis in the Han Chinese PopulationWeilin Pu, Wenyu Wu, Qingmei Liu, et al.
Clinical and Experimental Rheumatology|August 29, 2015
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosisEguzkine Ochoa, José-Ezequiel Martin, Shervin Assasi, et al.
Annals of the Rheumatic Diseases|February 28, 2013
New insight on the Xq28 association with systemic sclerosisF David Carmona, M Carmen Cénit, Lina-Marcela Diaz-Gallo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 26, 2019
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialDinesh Khanna, Cathie Spino, Sindhu Johnson, et al.
Arthritis Care & Research|April 20, 2026
Discordance between patient and physician global assessments in early systemic sclerosisEllen Romich, Alexis Ogdie, Alisa Stephens-Shields, et al.
Arthritis Research & Therapy|January 22, 2016
Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patientsMinghua Wu, Shervin Assassi, Gloria A Salazar, et al.
BMJ Open|August 10, 2013
The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease contextLinda Kwakkenbos, Lisa R Jewett, Murray Baron, et al.
Rheumatology (Oxford, England)|June 6, 2018
The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohortsDane H Dougherty, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Clinical and Experimental Rheumatology|January 17, 2012
New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN)Brett D Thombs, Lisa R Jewett, Shervin Assassi, et al.
Pageof 39